Assessment of the PCA3 test for prostate cancer diagnosis: A systematic review and meta-analysis;Evaluación del test PCA3 para el diagnóstico de cáncer de próstata: Revisión sistemática y metanlisis

Actas Urologicas Espanolas

Volumn 34, Issue 4, 2010, Pages 346-355

  Ruiz Aragon J ^a   Marquez Pelaez S ^a  

^a Agencia de Evaluacin de Tecnología Sanitaria de Andaluca AETSA   (Spain)

Author keywords

Diagnosis; Early detection; PCA3; Prostate cancer

Indexed keywords

PROSTATE CANCER ANTIGEN 3, HUMAN; TUMOR ANTIGEN;

HUMAN; MALE; META ANALYSIS; PROSTATE TUMOR; REVIEW;

ANTIGENS, NEOPLASM; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 77954516110     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2010.02.019     Document Type: Article

References (32)

1. S. Granado de la Orden, C. Sa Requejo, and A. Quints Viqueira Situacin epidemiolgica del cáncer de próstata en Espaa Actas Urol Esp 30 2006 574 582
2. J. Raja, N. Ramachandran, G. Munneke, and U. Patel Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer Clin Radiol 61 2006 142 153
3. Y. Fradet, F. Saad, A. Aprikian, J. Dessureault, M. Elhilali, and C. Trudel UPM3, a new molecular urine test for the detection of prostate cancer Urology 64 2004 311 315
4. R.J. Babaian, D.A. Johnston, W. Naccarato, A. Ayala, V.A. Bhadkamkar, and H.A. Fritsche Jr The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy J Urol 165 2001 757 760
5. W.J. Catalona, D.S. Smith, and D.K. Ornstein Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination: enhancement of specificity with free PSA measurements JAMA 277 1997 1452 1455
6. K.A. Roehl, J.A. Antenor, and W.J. Catalona Serial biopsy results in prostate cancer screening study J Urol 167 2002 2435 2439
7. J. Groskopf, S. Aubin, I.L. Deras, A. Blase, S. Bodrug, and C. Clark APTIMA PCA3 molecular urine test: development of a meted to aid in the diagnosis of prostate cancer Clin Chem 52 2006 1089 1095
8. L.S. Marks, Y. Fradet, I.L. Deras, A. Blase, J. Mathis, and S. Aubin PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy Urology 69 2007 532 535
9. S.J. Freedland, and A.W. Partin Detecting prostate cancer with molecular markers: uPM3 Rev Urol 7 2005 236 238
10. M. Overmyer New PCA assay aids critical diagnostic decisions. Urology Times. The leading new source for urologists 2006 2006 Ed: Advanstar publication USA
11. Busse U, Chipre C, Fradet Y. Diagnocure Inc. RNA mensajero del PCA3 en tejidos benignos y malignos de prstata. Oficina Espaola de Patentes y Marcas. N° 2 260 059. 17/07/2002
12. P. Whiting, A.W.S. Rutjes, J.B. Reitsma, P.M.M. Bossuyt, and J. Kleijnen The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 2003 25 38
13. L. Oliveira Reis, A. Deeke Sasse, W.A. Matheus, F. Denardi, R. Mamprim Stopiglia, and M. Moreira da Silva Cáncer de prstata: prctica Clínica basada en la evidencia Actas Urol Esp 33 2009 344 350
14. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.F. Stroup Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses Lancet 354 1999 1896 1900
15. B. Ouyang, B. Bracken, B. Burke, E. Chung, J. Liang, and S.M. Ho A Duplex Quantitative Polymerase Chain Reaction Assay Based on Quantification of alpha-Methylacyl-CoA Racemase Transcripts and Prostate Cancer Antigen 3 in Urine Sediments Improved Diagnostic Accuracy for Prostate Cancer J Urol 181 2009 2508 2514
16. S.B. Shappell, J. Fulmer, D. Arguello, B.S. Wright, J.R. Oppenheimer, and M.J. Putzi PCA3 Urine mRNA Testing for Prostate Carcinoma: Patterns of Use by Community urologists and Assay Performance in Reference Laboratory Setting Urology 73 2009 363 368
17. R. Wang, A.M. Chinnaiyan, R.L. Dunn, K.J. Wojno, and J.T. Wei Rational Approach to Implementation of Prostate Cancer Antigen 3 Into Clinical Care Cancer 115 2009 3879 3886
18. A. Haese, A. de la Taille, H. van Poppel, M. Marberger, A. Stenzl, and P.F. Mulders Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy Eur Urol 54 2008 1081 1088
19. I.L. Deras, S.M. Aubin, A. Blase, J.R. Day, S. Koo, and A.W. Partin PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome J Urol 179 2008 1587 1592
20. H. Nakanishi, J. Groskopf, H.A. Fritsche, V. Bhadkamkar, A. Blase, and S.V. Kumar PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance J Urol 179 2008 1804 1809
21. B. Laxman, D.S. Morris, J. Yu, J. Siddiqui, J. Cao, and R. Mehra A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer Cancer Res 68 2008 645 649
22. M. Van Gils, D. Hessels, O. van Hooij, S. Jannink, W. Peelen, and S. Hanssen The time-resolved fluoresecence-based PCA3 test on urinary sediments after digital rectal examination; a dutch multicenter validation of the diagnostic performance Clin Cancer Res 13 2007 939 943
23. M. Van Gils, E. Cornel, D. Hessels, W. Peelen, J. Witjes, and P. Mulders Molecular PCA3 Diagnostics on prostatic fluids Prostate 67 2007 881 888
24. PCA3 RNA analysis in urine-a new perspective for detecting prostate cancer Eur Urol 46 2004 182 187
25. PCA3-based molecular urine analysis for the diagnosis of prostate cancer Eur Urol 44 2003 8 16
26. Prostate cancer gene 3 (Progensa PCA3) assay in the diagnosis of prostate cancer. Horizon Scanning Technology Briefing. National Horizon Scanning Centre. National Horizon Scanning Centre. Diciembre 2006.
27. E.A. Herness, and R.K. Naz A novel human prostate-specific gene (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis Cancer Res 63 2003 329 336
28. J. Luo, S. Zha, W.R. Gage, T.A. Dunn, J.L. Hicks, and C.J. Bennett Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer Cancer Res 62 2002 2220 2226
29. K.S. Korkmaz, C. Elbi, C.G. Korkmaz, M. Loda, G.L. Hager, and F. Saatcioglu Molecular cloning and characterization of STAMP1, a highly prostate specific six transmembrane protein that is over expressed in prostate cancer J Biol Chem 277 2002 3689 3696
30. L. Tsavaler, M.H. Shapero, S. Morkowski, and R. Laus Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins Cancer Res 61 2001 3760 3769
31. U. Schmidt, S. Fuessel, R. Koch, G.B. Baretton, A. Lohse, and S. Tomasetti Quantitative multi-gene expression profiling of primary prostate cancer Prostate 66 2006 1521 1534
32. J.V. Tricoli, M. Schoenfeldt, and B.A. Conley Detection of prostate cancer and predicting progression: Current and future diagnostic markers Clin Cancer Res 10 2004 3943 3953